Free Access
Issue
J Extra Corpor Technol
Volume 47, Number 3, September 2015
Page(s) 155 - 159
DOI https://doi.org/10.1051/ject/201547155
Published online 15 September 2015
  1. Güvener M, Korun O, Demirtürk OS.Risk factors for systemic inflammatory response after congenital cardiac surgery. J Card Surg. 2015;30:92–6. [CrossRef] [Google Scholar]
  2. Durandy Y. Minimizing systemic inflammation during cardiopulmonary bypass in the pediatric population. Artif Organs. 2014;38:11–8. [CrossRef] [PubMed] [Google Scholar]
  3. Asimakopoulos G. Systemic inflammation and cardiac surgery: An update. Perfusion. 2001;16:353–60. [CrossRef] [PubMed] [Google Scholar]
  4. Augoustides JGT. The inflammatory response to cardiac surgery with cardiopulmonary bypass: Should steroid prophylaxis be routine?J Cardiothorac Vasc Anesth. 2012;26:952–8. [CrossRef] [Google Scholar]
  5. Mahle WT, Matthews E, Kanter KR, Kogon BE, Hamrick SEG, Strickland MJ. Inflammatory response after neonatal cardiac surgery and its relationship to clinical outcomes. Ann Thorac Surg. 2014;97:950–6. [CrossRef] [Google Scholar]
  6. Scrascia G, Rotunno C, Guida P, et al. Perioperative steroids administration in pediatric cardiac surgery: A meta-analysis of randomized controlled trials. Pediatr Crit Care Med. 2014;15:435–42. [CrossRef] [PubMed] [Google Scholar]
  7. Warren OJ, Watret AL, de Wit KL, et al. The inflammatory response to cardiopulmonary bypass: Part 2-Anti-inflammatory therapeutic strategies. J Cardiothorac Vasc Anesth. 2009;23:384–93. [CrossRef] [Google Scholar]
  8. Kats S, Schönberger JPAM, Brands R, et al. Endotoxin release in cardiac surgery with cardiopulmonary bypass: Pathophysiology and possible therapeutic strategies-An update. Eur J Cardiothorac Surg. 2011;39:451–8. [CrossRef] [Google Scholar]
  9. Chaney MA. Corticosteroids and cardiopulmonary bypass: A review of clinical investigations. Chest. 2002;121:921–31. [CrossRef] [PubMed] [Google Scholar]
  10. Whitlock RP, Rubens FD, Young E, et al. Pro: Steroids should be used for cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2005;19:250–4. [CrossRef] [Google Scholar]
  11. Ng CS, Wan S. Limiting inflammatory response to cardiopulmonary bypass: Pharmaceutical strategies. Curr Opin Pharmacol. 2012;12:155–9. [CrossRef] [Google Scholar]
  12. Schroeder VA, Pearl JM, Schwartz SM, et al. Combined steroid treatment for congenital heart surgery improves oxygen delivery and reduces post bypass inflammatory mediator expression. Circulation. 2003;107:2823–8. [CrossRef] [PubMed] [Google Scholar]
  13. Pasquali SK, Hall M, Li JS, et al. Corticosteroids and outcome in children undergoing congenital heart surgery. Circulation. 2010;122:2123–30. [CrossRef] [PubMed] [Google Scholar]
  14. Mastropietro CW, Barrett R, Davalos MC, et al. Cumulative corticosteroid exposure and infection risk after complex pediatric cardiac surgery. Ann Thorac Surg. 2013;95:2133–9. [CrossRef] [Google Scholar]
  15. Keski-Nisula J, Pesonen E, Olkkola KT, et al. Methylprednisolone in neonatal cardiac surgery: Reduced inflammation without improved clinical outcome. Ann Thorac Surg. 2013;95:2126–32. [CrossRef] [Google Scholar]
  16. Graham EM, Atz AM, McHugh KE, et al. Preoperative steroid treatment does not improve markers of inflammation after cardiac surgery in neonates: Results from a randomized trial. J Thorac Cardiovasc Surg. 2014;147:902–8. [CrossRef] [Google Scholar]
  17. Pasquali SK, Li JS, He X, et al. Perioperative methylprednisolone and outcome in neonates undergoing heart surgery. Pediatrics. 2012;129:e385–91. [CrossRef] [PubMed] [Google Scholar]
  18. Clancy RR, McGaurn SA, Wernovsky G, et al. Preoperative risk-of-death prediction model in heart surgery with deep hypothermic circulatory arrest in the neonate. J Thorac Cardiovasc Surg. 2000;119:347–57. [CrossRef] [Google Scholar]
  19. Darling E, Harris-Holloway S, Kern FH, et al. Impact of modifying priming components and fluid administration using miniaturized circuitry in neonatal cardiopulmonary bypass. Perfusion. 2000;15:3–12. [CrossRef] [PubMed] [Google Scholar]
  20. Haydock MD, Kruger C, Willcox T, Haydock D. Does removing Mannitol and Voluven from the priming fluid of the cardiopulmonary bypass circuit have clinical effects?J Extra Corpor Technol. 2014;46:77–83. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.